Prevalence of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in a Tertiary Care Hospital in North India

doi:10.5281/zenodo.8363496

International Journal of Medical and Pharmaceutical Research

2023, Volume-4, Issue-5 doi: 10.5281/zenodo.8363496

Original Article

Prevalence of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in a Tertiary Care Hospital in North India

Veena Chaudhary

DOI : 10.5281/zenodo.8363496

Published

Sept. 19, 2023

Abstract

Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is one of the most common inherited hemolytic disorders occurring among humans.

Aim: In this study, the aim was to find out the prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in a group of students studying MBBS in a tertiary care hospital in North India.

Material & Methods: Student’s history information was collected in questionnaires and blood samples data were collected and reported.

Results: In this study, the results showed that the prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among a group of 600 students studying MBBS, evaluated at NCMCH in North India was nil (0%). The two-tailed P value was less than 0.0001***, in the Chi-square test. By conventional criteria, this difference was considered to be extremely statistically significant.

Conclusion: It is concluded that the prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in a group of 600 students studying MBBS in NCMCH in North India was nil in our study

Recommended Articles

Volume-4, Issue-5

Downloads

Download PDF pdf

Download XML

Citations

2441 Views

384 Downloads

Share this article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.